CIRCANOL Drug Patent Profile
✉ Email this page to a colleague
When do Circanol patents expire, and when can generic versions of Circanol launch?
Circanol is a drug marketed by 3M and is included in two NDAs.
The generic ingredient in CIRCANOL is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Circanol
A generic version of CIRCANOL was approved as ergoloid mesylates by SUN PHARM INDUSTRIES on October 31st, 1991.
Summary for CIRCANOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CIRCANOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CIRCANOL
US Patents and Regulatory Information for CIRCANOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3m | CIRCANOL | ergoloid mesylates | TABLET;SUBLINGUAL | 084868-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
3m | CIRCANOL | ergoloid mesylates | TABLET;SUBLINGUAL | 085809-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |